← Browse by Condition
Medical Condition

dlbcl diffuse large b cell lymphoma

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2
NCT07249905 Phase 1, Phase 2
Recruiting

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

Enrollment
180 pts
Location
Australia
Sponsor
ModeX Therapeutics, An OPKO He...
View Trial →
NCT06299553
Recruiting

Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)

Enrollment
200 pts
Location
Italy
Sponsor
Incyte Biosciences Italy S.r.l
View Trial →
NCT07057765
Recruiting

Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL

Enrollment
40 pts
Location
Egypt
Sponsor
Ain Shams University
View Trial →